Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58,548,563
-
Total 13F shares
-
32,818,307
-
Share change
-
-1,031,249
-
Total reported value
-
$87,622,240
-
Put/Call ratio
-
98%
-
Price per share
-
$2.68
-
Number of holders
-
79
-
Value change
-
-$35,920,780
-
Number of buys
-
49
-
Number of sells
-
41
Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q1 2023
As of 31 Mar 2023,
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,818,307 shares.
The largest 10 holders included
Soleus Capital Management, L.P., ORBIMED ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Candriam S.C.A., WASATCH ADVISORS LP, Cormorant Asset Management, LP, and BlackRock Inc..
This page lists
79
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.